| 000 | 01649 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516012428.0 | ||
| 264 | 0 | _c20110804 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1559-0100 | ||
| 024 | 7 |
_a10.1007/s12020-010-9423-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJansen, H J | |
| 245 | 0 | 0 |
_aContribution of change in glycosylated haemoglobin to insulin-associated weight gain: results of a longitudinal study in type 2 diabetic patients. _h[electronic resource] |
| 260 |
_bEndocrine _cApr 2011 |
||
| 300 |
_a190-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperglycemia _xepidemiology |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 |
_aInsulin _xadverse effects |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMedical Records |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNetherlands _xepidemiology |
| 650 | 0 | 4 |
_aObesity _xcomplications |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aStatistics as Topic |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aWeight Gain _xdrug effects |
| 700 | 1 | _aHendriks, J C | |
| 700 | 1 | _ade Galan, B E | |
| 700 | 1 | _aPenders, G | |
| 700 | 1 | _aTack, C J | |
| 700 | 1 | _aVervoort, G | |
| 773 | 0 |
_tEndocrine _gvol. 39 _gno. 2 _gp. 190-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12020-010-9423-4 _zAvailable from publisher's website |
| 999 |
_c20367529 _d20367529 |
||